Bong-Yong Lee
Directeur/Membre du Conseil chez Neomics Co., Ltd.
Profil
Bong-Yong Lee is currently a Director at Neomics Co., Ltd.
and a Director at ImmunoMet Therapeutics, Inc. He previously worked as a Director at HANALL BIOPHARMA Co., Ltd., Chief Scientific Officer & Executive Director at Daewoong Pharmaceutical Co., Ltd., Non-Executive Director at Bio-Synectics, Inc., and Chief Scientific Officer at SK Chemicals Co. Ltd.
He also worked as a Professor at Kyung Hee University.
Lee received his undergraduate degree from Seoul National University and his graduate degree from The State University of New York.
Postes actifs de Bong-Yong Lee
| Sociétés | Poste | Début |
|---|---|---|
Neomics Co., Ltd.
 Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Neomics Co., Ltd. develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer. It provides services of custom antibody and protein production and offers antibody groups including in-house antibodies from aminoacyl-tRNA synthesize. The company was founded by Chi Uk In in 2005 and is headquartered in Seoul, South Korea. | Directeur/Membre du Conseil | - |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | 01/07/2015 |
Anciens postes connus de Bong-Yong Lee
| Sociétés | Poste | Fin |
|---|---|---|
| BIO-SYNECTICS, INC. | Directeur/Membre du Conseil | - |
| HANALL BIOPHARMA CO., LTD. | Directeur/Membre du Conseil | - |
| DAEWOONG PHARMACEUTICAL CO., LTD | Directeur Technique/Scientifique/R&D | 31/12/2014 |
Kyung Hee University
 Kyung Hee University Other Consumer ServicesConsumer Services Kyung Hee University provides academic courses and grants academic degrees. It has udergraduate, graduate, international student, and international faculty programs. The firm also provides scholarships and operates Kyung Hee Medical Center, Kyung Hee University Hospital at Gangdong, and Kangnam Korean Hospital. The company was founded on February 15, 1949 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | - |
SK Chemicals Co. Ltd. /Old/
 SK Chemicals Co. Ltd. /Old/ Chemicals: SpecialtyProcess Industries SK Chemicals Co. Ltd. engages in the manufacture of chemicals and develops synthetic and natural drugs. It operates through the following business divisions: Green Chemicals and Life Science. The Green Chemicals division offers high performance polyethylene terephthalate glycol resins, polyester binders, water treatment chemicals, coolant and antifreeze, chemicals for housing, industrial biocide, polyethylene terephthalate resins, carbon fiber composite, acoustic absorption materials and acoustic thermal insulation and biodiesel. The Life Science division provides musculoskeletal, gastrointestinal, cardiovascular, urology, antibiotics, blood preparations, vaccines, parenteral nutrition and other prescription (Rx). The company was founded on July 1, 1969 and is headquartered in Seongnam, South Korea. | Directeur Technique/Scientifique/R&D | - |
Formation de Bong-Yong Lee
| The State University of New York | Graduate Degree |
| Seoul National University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HANALL BIOPHARMA CO., LTD. | Health Technology |
| DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
| BIO-SYNECTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
SK Chemicals Co. Ltd. /Old/
SK Chemicals Co. Ltd. /Old/ Chemicals: SpecialtyProcess Industries SK Chemicals Co. Ltd. engages in the manufacture of chemicals and develops synthetic and natural drugs. It operates through the following business divisions: Green Chemicals and Life Science. The Green Chemicals division offers high performance polyethylene terephthalate glycol resins, polyester binders, water treatment chemicals, coolant and antifreeze, chemicals for housing, industrial biocide, polyethylene terephthalate resins, carbon fiber composite, acoustic absorption materials and acoustic thermal insulation and biodiesel. The Life Science division provides musculoskeletal, gastrointestinal, cardiovascular, urology, antibiotics, blood preparations, vaccines, parenteral nutrition and other prescription (Rx). The company was founded on July 1, 1969 and is headquartered in Seongnam, South Korea. | Process Industries |
Neomics Co., Ltd.
Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Neomics Co., Ltd. develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer. It provides services of custom antibody and protein production and offers antibody groups including in-house antibodies from aminoacyl-tRNA synthesize. The company was founded by Chi Uk In in 2005 and is headquartered in Seoul, South Korea. | Health Technology |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
